Integration of Fluid Dynamics and Cellular Activities in Modeling of Bioreactors Biopharmaceuticals was once a scientific exploration but now, with global revenue of more than $160 billion, it is a business mainstream growing at the annual rate of 8%. An industry thriving at this pace needs faster and more reliable tools for option ranking and alternative evaluation. Our research aims to deliver such tools.
Biopharmaceuticals was once a scientific exploration but now, with global revenue of more than $160 billion, it is a business mainstream growing at the annual rate of 8%. An industry thriving at this pace needs faster and more reliable tools for option ranking and alternative evaluation. Our research aims to deliver such tools.
